WASHINGTON — New details and never-before-seen renderings of the Washington Commanders' massive $3.7 billion stadium project ...
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
It's been eight months since Kansas submitted a SNAP waiver request to USDA asking permission to ban food stamps from buying ...
Drugmakers told the FDA that inflexible post-approval change requirements are among the top regulatory barriers to the ...
This article explores the US and EU compliance requirements to ensure patient safety for GMP ancillary materials in cell and ...
[SINGAPORE] The Ministry of Digital Development and Information (MDDI) and the Infocomm Media Development Authority (IMDA) have released a public consultation paper that proposes changes to the ...
Arden Farhi is the managing editor for CBS News' Washington bureau. He has covered several presidential campaigns and the Obama, Trump and Biden administrations. His executive producer credit include ...
A combination of a relatively low-risk approval process, growing sales, and a very attractive valuation based on management's peak sales estimations makes this biotech stock attractive. The company's ...
Rival efforts from Netflix and Paramount could upend the media industry. Paramount launched a hostile bid for Warner Bros. Discovery this week, just days after Netflix struck a deal to acquire the ...
Hosted on MSN
Dr. Gottlieb: FDA is systemically trying to dismantle components of the vaccine approval process
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss concerns over the FDA's sweeping changes to how the U.S. handles vaccinations, impact on the public trust in vaccines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback